Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Primary and Booster Vaccination in HIV-Infected and Uninfected Infants
NCT00829010Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Jun 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00829010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829010.